Drugs that contain Glycopyrrolate
1. Cuvposa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7816396 | MERZ PHARMS | Method for increasing the bioavailability of glycopyrrolate |
Aug, 2023
(8 months ago) | |
| US7638552 | MERZ PHARMS | Method for increasing the bioavailability of glycopyrrolate |
Aug, 2023
(8 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Jul 28, 2017 |
| New Product(NP) | Jul 28, 2013 |
Market Authorisation Date: 28 July, 2010
Treatment: Reduce chronic severe drooling (i.e., sialorrhea) in patients with neurologic conditions associated with problem drooling
Dosage: SOLUTION;ORAL
CUVPOSA family patents
2. Lonhala Magnair Kit patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6962151 | SUMITOMO PHARMA AM | Inhalation nebulizer |
Oct, 2020
(3 years ago) | |
| US7316067 | SUMITOMO PHARMA AM | Forming a perforate membrane by laser drilling and a subsequent electro-polishing step |
Sep, 2022
(1 year, 7 months ago) | |
| US8511581 | SUMITOMO PHARMA AM | Fluid droplet production apparatus and method |
Nov, 2023
(5 months ago) | |
| US7458372 | SUMITOMO PHARMA AM | Inhalation therapy device |
Nov, 2024
(6 months from now) | |
| US7931212 | SUMITOMO PHARMA AM | Fluid droplet production apparatus and method |
Nov, 2025
(1 year, 7 months from now) | |
| US11278683 | SUMITOMO PHARMA AM | Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized |
Aug, 2026
(2 years from now) | |
| US9265900 | SUMITOMO PHARMA AM | Disposable ampoule for an aerosol generating device |
Dec, 2028
(4 years from now) | |
| US10940110 | SUMITOMO PHARMA AM | Method and system for the treatment of chronic COPD with nebulized anticholinergic administrations |
Feb, 2029
(4 years from now) | |
| US9789270 | SUMITOMO PHARMA AM | Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized |
Oct, 2030
(6 years from now) | |
| US9168556 | SUMITOMO PHARMA AM | Membrane nebulizer and method for welding a membrane to a carrier during the production of a membrane nebulizer |
Sep, 2032
(8 years from now) | |
| US9604018 | SUMITOMO PHARMA AM | Aerosol therapy device |
May, 2033
(9 years from now) | |
| US10376661 | SUMITOMO PHARMA AM | Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element |
Sep, 2035
(11 years from now) | |
| US10688518 | SUMITOMO PHARMA AM | Method of manufacturing a vibratable head for an aerosol generator and vibratable head for an aerosol generator |
Nov, 2036
(12 years from now) | |
| US10744277 | SUMITOMO PHARMA AM | Aerosol delivery device and method of operating the aerosol delivery device |
Dec, 2036
(12 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Dec 05, 2020 |
Market Authorisation Date: 05 December, 2017
Treatment: Long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd); A method of using an aerosol delivery device to aerosolize glycopyrrolate for the ...
Dosage: SOLUTION;INHALATION
LONHALA MAGNAIR KIT family patents
3. Robinul patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7091236 | CASPER PHARMA LLC | Method for increasing the bioavailability of glycopyrrolate |
Apr, 2024
(3 days from now) | |
Treatment: For use as adjunctive therapy in the treatment of peptic ulcer
Dosage: TABLET;ORAL
ROBINUL family patents
4. Robinul Forte patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7091236 | CASPER PHARMA LLC | Method for increasing the bioavailability of glycopyrrolate |
Apr, 2024
(3 days from now) | |
Treatment: For use as adjunctive therapy in the treatment of peptic ulcer
Dosage: TABLET;ORAL
ROBINUL FORTE family patents
5. Seebri patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6521260 | NOVARTIS | Carrier particles for use in dry powder inhalers |
Jan, 2016
(8 years ago) | |
| US6582678 | NOVARTIS | Carrier particles for use in dry powder inhalers |
Apr, 2018
(5 years ago) | |
| US6528678 | NOVARTIS | Phosgene-free process for preparing carbamates |
Apr, 2018
(5 years ago) | |
| US7229607 | NOVARTIS | Treatment of respiratory disease |
Apr, 2021
(3 years ago) | |
| US8029768 | NOVARTIS | Treatment of respiratory diseases |
Apr, 2021
(3 years ago) | |
| US8303991 | NOVARTIS | Method of making particles for use in a pharmaceutical composition |
Jun, 2021
(2 years ago) | |
| US8956661 | NOVARTIS | Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof |
Jun, 2021
(2 years ago) | |
| US8435567 | NOVARTIS | Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation |
Jun, 2021
(2 years ago) | |
| US9931304 | NOVARTIS | Method of making particles for use in a pharmaceutical composition |
Jun, 2021
(2 years ago) | |
| US7736670 | NOVARTIS | Method of making particles for use in a pharmaceutical composition |
Jun, 2021
(2 years ago) | |
| US9962338 | NOVARTIS | Method of making particles for use in a pharmaceutical composition |
Jun, 2021
(2 years ago) | |
| US8048451 | NOVARTIS | Pharmaceutical compositions for inhalation |
Jun, 2021
(2 years ago) | |
| US8580306 | NOVARTIS | Particles for use in a pharmaceutical composition |
Jun, 2021
(2 years ago) | |
| US8479730 | NOVARTIS | Inhaler device |
Oct, 2028
(4 years from now) | |
| US8182838 | NOVARTIS | Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
Oct, 2028
(4 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Oct 29, 2018 |
Market Authorisation Date: 29 October, 2015
Treatment: Long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd)
Dosage: POWDER;INHALATION
SEEBRI family patents